| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 109,5 M € | +6.4% | 102,9 M € | +20.0% | 85,8 M € | +5.8% | 81,1 M € | +11.7% | 72,5 M € | +6.8% | 67,9 M € | +6.6% | 63,7 M € | +3.3% | 61,7 M € | +2.8% | 60,0 M € | -2.5% | 61,5 M € | +3.3% | 59,5 M € | +3.7% | 57,4 M € | -0.5% | 57,7 M € | +0.3% | 57,6 M € | +3.4% | 55,6 M € | +4.1% | 53,4 M € | +1.4% | 52,7 M € | +3.1% | 51,1 M € | +6.6% | 48,0 M € | +7.3% | 44,7 M € | |
| EBITDA | 4,4 M € | -12.5% | 5,1 M € | +29.5% | 3,9 M € | +10.2% | 3,6 M € | +24.4% | 2,9 M € | -0.7% | 2,9 M € | +1.6% | 2,8 M € | +18.8% | 2,4 M € | -2.2% | 2,4 M € | -2.5% | 2,5 M € | +10.1% | 2,3 M € | +11.2% | 2,0 M € | -20.7% | 2,6 M € | +33.2% | 1,9 M € | -11.5% | 2,2 M € | +2.1% | 2,1 M € | -11.5% | 2,4 M € | -8.6% | 2,6 M € | -4.1% | 2,8 M € | +25.8% | 2,2 M € | |
| Operating profit | 2,7 M € | -9.2% | 3,0 M € | +35.2% | 2,2 M € | +42.2% | 1,5 M € | +29.2% | 1,2 M € | +23.8% | 963,8 k € | -15.3% | 1,1 M € | +48.6% | 765,5 k € | -19.3% | 948,0 k € | -22.2% | 1,2 M € | +32.3% | 920,6 k € | +46.9% | 626,7 k € | -48.7% | 1,2 M € | +67.0% | 730,9 k € | -32.4% | 1,1 M € | -6.1% | 1,2 M € | -22.7% | 1,5 M € | -18.2% | 1,8 M € | -10.2% | 2,0 M € | +29.8% | 1,6 M € | |
| Profit/loss | 3,8 M € | -26.8% | 5,2 M € | +385.8% | 1,1 M € | +62.1% | 654,4 k € | -88.4% | 5,6 M € | +1346.4% | 388,5 k € | -6.6% | 415,9 k € | +168.2% | 155,0 k € | -65.6% | 450,1 k € | +24.9% | 360,4 k € | +320.7% | 85,7 k € | -38.6% | 139,5 k € | -61.0% | 357,6 k € | +343.8% | 80,6 k € | -75.5% | 329,0 k € | +268.7% | 89,2 k € | -78.4% | 412,8 k € | -35.6% | 641,5 k € | -8.6% | 702,1 k € | +95.9% | 358,4 k € | |
| Equity | 24,0 M € | +18.6% | 20,2 M € | +47.2% | 13,7 M € | +8.3% | 12,7 M € | +5.4% | 12,0 M € | +87.4% | 6,4 M € | +6.3% | 6,0 M € | +7.2% | 5,6 M € | +2.6% | 5,5 M € | +8.7% | 5,1 M € | +7.4% | 4,7 M € | +1.6% | 4,6 M € | +2.9% | 4,5 M € | +8.4% | 4,1 M € | +1.7% | 4,1 M € | +8.5% | 3,8 M € | +2.0% | 3,7 M € | +12.1% | 3,3 M € | +23.6% | 2,7 M € | +27.1% | 2,1 M € | |
| Total assets | 73,8 M € | +17.0% | 63,1 M € | +21.0% | 52,1 M € | +1.4% | 51,4 M € | +2.5% | 50,1 M € | +22.6% | 40,9 M € | +11.8% | 36,6 M € | +0.1% | 36,5 M € | +7.2% | 34,1 M € | +2.0% | 33,4 M € | +1.2% | 33,0 M € | +4.7% | 31,5 M € | +7.1% | 29,4 M € | -1.0% | 29,7 M € | -0.2% | 29,8 M € | +5.0% | 28,4 M € | +0.9% | 28,1 M € | +10.4% | 25,5 M € | +8.7% | 23,4 M € | +3.1% | 22,7 M € | |
| Cash | 512,7 k € | -3.8% | 533,2 k € | -0.9% | 538,1 k € | +13.5% | 474,3 k € | +18.1% | 401,7 k € | +30.6% | 307,6 k € | -13.0% | 353,7 k € | +2.6% | 344,8 k € | -35.5% | 534,6 k € | +54.1% | 347,0 k € | +11.1% | 312,4 k € | +4.1% | 300,2 k € | -0.6% | 302,0 k € | -16.6% | 362,1 k € | +2.3% | 353,8 k € | +23.3% | 287,0 k € | +8.7% | 264,0 k € | -2.1% | 269,7 k € | -6.8% | 289,5 k € | -28.3% | 403,6 k € | |
| Debts | 48,7 M € | +17.4% | 41,5 M € | +11.2% | 37,4 M € | -1.4% | 37,9 M € | +1.6% | 37,3 M € | +11.2% | 33,5 M € | +12.8% | 29,7 M € | -1.6% | 30,2 M € | +8.3% | 27,9 M € | +0.4% | 27,8 M € | +0.9% | 27,6 M € | +5.0% | 26,2 M € | +8.3% | 24,2 M € | -2.8% | 24,9 M € | -0.2% | 25,0 M € | +4.4% | 23,9 M € | +0.4% | 23,8 M € | +10.6% | 21,5 M € | +6.8% | 20,1 M € | +0.1% | 20,1 M € | |
| Staff | 340,1 | 330,7 | 334,9 | 315,4 | 293 | 283,4 | 278 | 274,7 | 271,5 | 264,2 | 264,4 | 251,8 | 242,2 | 241,4 | 237,4 | 231,1 | 229,5 | 242,2 | 240 | 237,2 | ||||||||||||||||||||
Cooperative society · Verviers · incorporated on 26/06/1913 · 340,1 ETP
Cooperative society profitable and well capitalised.
Solid counterparty for a standard engagement.
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT is a Cooperative society incorporated in 1913. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Verviers. It employs on average 340,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette